Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted Protein Acetylation in Cells Using Heterobifunctional Molecules
Wei Wang, Liyun Chen, Jacob M. Wozniak, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 40, pp. 16700-16708
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Chasing molecular glue degraders: screening approaches
Ana Domostegui, Luis Nieto‐Barrado, Carles Perez‐Lopez, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 13, pp. 5498-5517
Open Access | Times Cited: 103
Targeted protein degradation: from mechanisms to clinic
Jonathan M. Tsai, Radosław P. Nowak, Benjamin L. Ebert, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 9, pp. 740-757
Closed Access | Times Cited: 95
Proximity-Based Modalities for Biology and Medicine
Xingui Liu, Alessio Ciulli
ACS Central Science (2023) Vol. 9, Iss. 7, pp. 1269-1284
Open Access | Times Cited: 85
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16
Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors
Liwen Hua, Qiuyue Zhang, Xinyue Zhu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 12, pp. 8091-8112
Closed Access | Times Cited: 47
DNA-encoded library-enabled discovery of proximity-inducing small molecules
Jeremy W. Mason, Yuen Ting Chow, Liam Hudson, et al.
Nature Chemical Biology (2023) Vol. 20, Iss. 2, pp. 170-179
Open Access | Times Cited: 38
Targeted protein posttranslational modifications by chemically induced proximity for cancer therapy
Yunhua Peng, Jing Liu, Hiroyuki Inuzuka, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 4, pp. 104572-104572
Open Access | Times Cited: 31
The rise of degrader drugs
Mingxing Teng, Nathanael S. Gray
Cell chemical biology (2023) Vol. 30, Iss. 8, pp. 864-878
Open Access | Times Cited: 28
Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53
Md Kabir, Ning Sun, Xiao Hu, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 27, pp. 14932-14944
Closed Access | Times Cited: 27
Targeted Biomolecule Regulation Platform: A Split-and-Mix PROTAC Approach
Fenfang Yang, Qinhong Luo, Yuechen Wang, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 14, pp. 7879-7887
Closed Access | Times Cited: 26
Targeted Protein O-GlcNAcylation Using Bifunctional Small Molecules
Bowen Ma, Khadija Shahed Khan, Tongyang Xu, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 14, pp. 9779-9789
Open Access | Times Cited: 13
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors
Florian Wittlinger, Blessing C. Ogboo, Ekaterina Shevchenko, et al.
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 10
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access | Times Cited: 1
Kinase-targeting small-molecule inhibitors and emerging bifunctional molecules
Georg L. Goebel, Xiaqiu Qiu, Peng Wu
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 10, pp. 866-881
Closed Access | Times Cited: 28
Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence
Miquel Duran‐Frigola, Marko Cigler, Georg E. Winter
Journal of the American Chemical Society (2023) Vol. 145, Iss. 5, pp. 2711-2732
Open Access | Times Cited: 20
Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics
Ana P. Teixeira, Martin Fussenegger
Advanced Science (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 20
Proximity-inducing modalities: the past, present, and future
Sameek Singh, Wenzhi Tian, Zachary C. Severance, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 16, pp. 5485-5515
Closed Access | Times Cited: 17
Generative design of therapeutics that bind and modulate protein states
Tianlai Chen, Lauren Hong, Vivian Yudistyra, et al.
Current Opinion in Biomedical Engineering (2023) Vol. 28, pp. 100496-100496
Closed Access | Times Cited: 13
Emerging TACnology: Heterobifunctional Small Molecule Inducers of Targeted Posttranslational Protein Modifications
Pascal Heitel
Molecules (2023) Vol. 28, Iss. 2, pp. 690-690
Open Access | Times Cited: 11
Degron tagging for rapid protein degradation in mice
Brianda Areli Hernández-Morán, Gillian C.A. Taylor, Álvaro Lorente‐Macías, et al.
Disease Models & Mechanisms (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 4
Small Molecule-Induced Post-Translational Acetylation of Catalytic Lysine of Kinases in Mammalian Cells
Guanghui Tang, Xuan Wang, Huisi Huang, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 34, pp. 23978-23988
Closed Access | Times Cited: 4
Methylarginine targeting chimeras for lysosomal degradation of intracellular proteins
Laurence J. Seabrook, Carolina N. Franco, Cody A. Loy, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 12, pp. 1566-1576
Closed Access | Times Cited: 4
Acetylation: a new target for protein degradation in cancer
Callie E. W. Crawford, George M. Burslem
Trends in cancer (2025)
Closed Access
Deubiquitinase-Targeting Chimeras (DUBTACs) as a Potential Paradigm-Shifting Drug Discovery Approach
Zonghui Ma, Mingxiang Zhou, Haiying Chen, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Native mass spectrometry for proximity-inducing compounds: a new opportunity for studying chemical-induced protein modulation
Emanuele Fabbrizi, Francesco Fiorentino, Fabrizio Casano, et al.
Expert Opinion on Drug Discovery (2025)
Closed Access
Page 1 - Next Page

Scroll to top